Tenaya Therapeutics (TNYA) Shares Issued (2020 - 2026)

Tenaya Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 126.09% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 126.09% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 30.22% from the prior year.
• Shares Issued eased to $2.7 million in Q1 2026 per TNYA's latest filing, from $12.1 million in the prior quarter.
• Across five years, Shares Issued topped out at $12.2 million in Q3 2025 and bottomed at $364108.0 in Q1 2024.
• The 5-year median for Shares Issued is $3.1 million (2022), against an average of $4.9 million.
• Across the five-year window, Shares Issued slumped 90.39% in 2024 and surged 803.79% in 2025, its largest moves.
• Year by year, Shares Issued stood at $5.2 million in 2022, then soared by 60.14% to $8.3 million in 2023, then increased by 10.91% to $9.3 million in 2024, then jumped by 30.22% to $12.1 million in 2025, then plunged by 77.71% to $2.7 million in 2026.
• Per Business Quant, the three latest TNYA Shares Issued figures stand at $2.7 million (Q1 2026), $12.1 million (Q4 2025), and $12.2 million (Q3 2025).